AVO announces £6m fundraise

Advanced Oncotherapy CEO Nicolas Serandour

Proton beam therapy specialist Advanced Oncotherapy (AVO) has announced a £6m equity fundraise to support its operations following news that it expects to treat the first patient with its next generation LIGHT system in the second half of next year. The fundraise has been conducted through a direct subscription for a total of 24,000,000 new ordinary shares of…

You must be a HM Subscriber to view this content.

Subscribe Now »